INOVIO Pharmaceuticals, Inc.
INOVIO Announces Pricing of Approximately $75 Million Public Offering
INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect…
Company newsroom
NASDAQ:INO
2 releases
INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect…
INOVIO delivers a new nonsurgical treatment option with a broad indication for adults living with RRP, a rare and debilitating disease that often…